These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20140196)

  • 1. Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.
    Epp E; Vanier G; Harcus D; Lee AY; Jansen G; Hallett M; Sheppard DC; Thomas DY; Munro CA; Mullick A; Whiteway M
    PLoS Pathog; 2010 Feb; 6(2):e1000753. PubMed ID: 20140196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence.
    Sanglard D; Ischer F; Marchetti O; Entenza J; Bille J
    Mol Microbiol; 2003 May; 48(4):959-76. PubMed ID: 12753189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90.
    LaFayette SL; Collins C; Zaas AK; Schell WA; Betancourt-Quiroz M; Gunatilaka AA; Perfect JR; Cowen LE
    PLoS Pathog; 2010 Aug; 6(8):e1001069. PubMed ID: 20865172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms.
    Uppuluri P; Nett J; Heitman J; Andes D
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1127-32. PubMed ID: 18180354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.
    Chen YL; Brand A; Morrison EL; Silao FG; Bigol UG; Malbas FF; Nett JE; Andes DR; Solis NV; Filler SG; Averette A; Heitman J
    Eukaryot Cell; 2011 Jun; 10(6):803-19. PubMed ID: 21531874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida albicans AGE3, the ortholog of the S. cerevisiae ARF-GAP-encoding gene GCS1, is required for hyphal growth and drug resistance.
    Lettner T; Zeidler U; Gimona M; Hauser M; Breitenbach M; Bito A
    PLoS One; 2010 Aug; 5(8):e11993. PubMed ID: 20700541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
    Vale-Silva LA; Coste AT; Ischer F; Parker JE; Kelly SL; Pinto E; Sanglard D
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans.
    Onyewu C; Wormley FL; Perfect JR; Heitman J
    Infect Immun; 2004 Dec; 72(12):7330-3. PubMed ID: 15557662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Effects and Mechanisms of Budesonide in Combination with Fluconazole against Resistant Candida albicans.
    Li X; Yu C; Huang X; Sun S
    PLoS One; 2016; 11(12):e0168936. PubMed ID: 28006028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
    Toutounji M; Tokajian S; Khalaf RA
    Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Small Molecule Inhibitor of Erg251 Makes Fluconazole Fungicidal by Inhibiting the Synthesis of the 14α-Methylsterols.
    Lu H; Li W; Whiteway M; Wang H; Zhu S; Ji Z; Feng Y; Yan L; Fang T; Li L; Ni T; Zhang X; Lv Q; Ding Z; Qiu L; Zhang D; Jiang Y
    mBio; 2023 Feb; 14(1):e0263922. PubMed ID: 36475771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M; Yan H; Lu M; Wang D; Sun S
    Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA array analysis of the differential expression change in virulence-related genes during the development of resistance in Candida albicans.
    Xu Z; Cao YB; Zhang JD; Cao YY; Gao PH; Wang DJ; Fu XP; Ying K; Chen WS; Jiang YY
    Acta Biochim Biophys Sin (Shanghai); 2005 Jul; 37(7):463-72. PubMed ID: 15999207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
    Lo HJ; Tseng KY; Kao YY; Tsao MY; Lo HL; Yang YL
    Int J Antimicrob Agents; 2015 Jun; 45(6):617-21. PubMed ID: 25802233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.
    Gamarra S; Rocha EM; Zhang YQ; Park S; Rao R; Perlin DS
    Antimicrob Agents Chemother; 2010 May; 54(5):1753-61. PubMed ID: 20194694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.